期刊文献+

临床药师参与诺卡菌并曲霉感染患者用药监护一例报告 被引量:2

原文传递
导出
摘要 诺卡菌是一组需氧的革兰染色阳性细菌,广泛存在于灰尘、土壤、污染的水源和腐烂的植物中。诺卡菌可引起肺部、皮肤、中枢神经系统及全身的播散性感染,多发生在免疫力低下患者,如器官移植、HIV感染及需长期口服激素者。肺诺卡菌病是由诺卡菌侵犯人体引起的少见但严重的化脓性或肉芽肿性疾病,可呈急性、亚急性或慢性过程,以慢性多见。肺诺卡菌病临床诊断难,易误诊为肺结核、肺真菌病、肺恶性肿瘤、肺脓肿等。本研究将从临床药师的角度,对1例抗中性粒细胞胞浆抗体(ANCA)相关性血管炎患者继发诺卡菌、真菌感染的主要治疗方案进行分析。
作者 冷丽丽
出处 《中国实用医刊》 2019年第18期122-122,F0003,F0004,共3页 Chinese Journal of Practical Medicine
  • 相关文献

参考文献1

二级参考文献15

  • 1GHANNOUM MA,KUHN DM.Voriconazole-better chances for patients with invasive mycoses[J].Eur J Med Res,2002,7 (5) :242-256.
  • 2PFALLER MA,DIEKEMA DJ,JONES RN,et al. International surveillance of bloodstream infections due to Candida species:frequency of occurrence and in vitro susceptibilities to fluconazole,ravuconazole,and voriconazole of isolates collected from 1997 through 19
  • 3ESPINEL-INGROFF A.In vitro activity of the new triazole voriconazole(UK-109,496)against opportunistic filamentous and dimorphic fungi and common and emerging yeast pathogens[J].J Clin Microbiol, 1998,36 ( 1 ) :198-202.
  • 4ESPINEL-INGROFF A.In vitro fungicidal activities of voriconazole,itraconazole,and amphotericin B against opportunistic moniliaceous and dematiaceous fungi[J].J Clin MicrobioI,2001,39 (3) :954-958.
  • 5CARRILLO AJ,GUARRO J.In vitro activities of four novel triazoles against Scedosporium spp[J].Antimicrob Agents Chemother, 2001,45 ( 7 ) :2151-2153.
  • 6PURKINS L,WOOD N,GHAHRAMANI P, et al. Pharmacokinetics and safety of voriconazole following intravenous-to oral-dose escalation regimens[J].Antimicrob Agents Chemother, 2002,46 (8) :2546-2553.
  • 7VENKATARAMANAN R, ZANG S,GAYOWSKI T, et al. Voriconazole inhibition of the metabolism of tacrolimus in a liver transplant recipient and in human liver microsomes[J].Antimicrob Agents Chemother,2002,46 (9) :3091-3093.
  • 8ROMERO A J, POGAMP PL,NILSSON LG, et al. Effect of voriconazole on the pharmacokinetics of cycrosporine in renal transplant patients[J].J Clin Pharmacol Ther,2002,71 (4) :226-234.
  • 9DENNING DW, RIBAUD P, MILPIED N,et al. Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis[J].Clin Infect Dis,2002,34 (5) :563-571.
  • 10HEBRECHT R,DENNING DW, PATTERSON TF, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis[J].N Engl J Med,2002,347 (6) :408-415.

共引文献38

同被引文献15

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部